Citrate and calcium kidney stones

Area of Science:

• Nephrology
• Metabolic Disorders
• Urology

Background:

• Citrate is vital in renal physiology, acting as a urinary base and inhibiting calcium stone formation.
• Hypocitraturia, a common abnormality in calcium nephrolithiasis, is a complex continuum influenced by acid-base status, diet, potassium, and renal handling.
• The prevalence of hypocitraturia is rising, linked to metabolic syndrome, obesity, and dietary changes.

Purpose of the Study:

• To provide an update on citrate biology, renal regulation, pathophysiology, and treatment of hypocitraturia.
• To emphasize interpreting urinary citrate levels within broader physiological and clinical contexts.
• To highlight hypocitraturia as a modifiable risk factor for precise risk stratification and individualized therapy in stone prevention.

Main Methods:

• Review of current literature on citrate metabolism, renal excretion, and hypocitraturia.
• Analysis of factors influencing urinary citrate levels, including acid-base status, diet, and potassium balance.
• Discussion of established and novel therapeutic interventions for hypocitraturia.

Main Results:

• Urinary citrate levels have varying implications based on systemic acid-base status and urinary calcium.
• Systemic acidosis, potassium deficiency, and altered renal citrate handling reduce urinary citrate, increasing stone risk.
• Potassium citrate is a primary therapy but requires caution in specific patient groups; citrate resistance is a challenge.

Conclusions:

• Urinary citrate interpretation requires consideration of physiological and clinical context.
• Hypocitraturia is a non-binary, modifiable risk factor in kidney stone disease.
• Individualized therapy and precise risk stratification are crucial for effective stone prevention, especially with overlapping abnormalities.